Scholars Central

Article

WCCCT 2020: Direct oral anticoagulants in preventing venous thromboembolism in ambulatory patients with cancer: A systematic review and meta-analysis- Dastynne

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Venous thromboembolism (VTE) is the second highest cause of mortality among cancer patients1. Routine thromboprophylaxis is not being given to ambulatory cancer patient based on recent guidelines. Methods: A literature search of randomized controlled trials evaluating the use of direct oral anticoagulants (DOACs) as prophylaxis for VTE among ambulatory cancer patients was conducted in the following databases: PubMed, Cochrane Library, CENTRAL, clinicaltrials.gov, and HERDIN. The primary outcome was the incidence of VTE and the secondary outcomes were major and nonmajor bleeding episodes. Two independent reviewers assessed the methodological quality of the studies using the Cochrane risk of bias tool. The random effects model for dichotomous data was used with a 95% confidence interval. Results: Two randomized controlled trials were included in this study (N=1404). The incidence of VTE among ambulatory cancer patients on DOACs was significantly decreased (OR 0.53; 95% CI 0.31-0.89, I2=31%). The rates of major (OR 1.97; 95% CI 0.88-4.43, I2=0%) and nonmajor (OR 1.37; 95% CI 0.79-2.37, I2=0%) bleeding were not statistically significant. Conclusion: This meta-analysis showed that the use of direct oral anticoagulants is associated with a statistically significant decrease in the rates of venous thromboembolism among high risk ambulatory cancer patients receiving chemotherapy. There was no statistically significant difference in the rates of major and non-major bleeding. DOACs can be used as primary VTE prophylaxis. Further evaluation on more homogeneous population of cancer patients and more powered studies is needed. Biography Dastynne Marie L. Dela Cruz, MD has completed her medical education at Pamantasan ng Lungsod ng MaynilaCollege of Medicine and is currently a first year medical resident at St. Luke’s Medical Center-Quezon City. Janine Audrei T. Pajimna, MD has completed her medical education at University of Santo Tomas Faculty of Medicine and is currently a first year medical resident at St. Luke’s Medical Center-Quezon City. This work is partly presented at 6th World Congress on Cardiology and Cardiovascular Therapeuticson August 24-25, 2020 held in Kyoto, Japan 6th World Congress on Cardiology and Cardiovascular Therapeuticson August 24-25, 2020 | Kyoto, Japan Volume 5, Issue 3

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Invasive and Non-Invasive Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Invasive and Non-Invasive Cardiology
  • SubjectCardiology